CLEARONE INC (CLRO) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
26/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseCLRO / S&P -6.46% / 15.20% |
LoseCLRO / S&P CLRO unavailable / 15.00% |
WinCLRO / S&P 54.35% / 50.40% |
| 2026-Q11/3 |
LoseCLRO / S&P -30.06% / -4.33% |
LoseCLRO / S&P -100.00% / 11.30% |
WinCLRO / S&P 114.03% / 27.70% |
| 2025-Q41/3 |
LoseCLRO / S&P -12.39% / 2.65% |
LoseCLRO / S&P -100.00% / 9.00% |
WinCLRO / S&P 225.56% / 13.40% |
| 2025-Q31/3 |
LoseCLRO / S&P 1.04% / 8.12% |
LoseCLRO / S&P -100.00% / 4.61% |
WinCLRO / S&P 351.66% / 13.45% |
| 2025-Q21/3 |
LoseCLRO / S&P -31.55% / 10.94% |
LoseCLRO / S&P -100.00% / 4.83% |
WinCLRO / S&P 291.62% / 10.63% |
| 2025-Q11/3 |
LoseCLRO / S&P -28.21% / -4.27% |
LoseCLRO / S&P -87.30% / 4.98% |
WinCLRO / S&P 8657.14% / 10.57% |
| 2024-Q42/3 |
WinCLRO / S&P 25.81% / 2.41% |
LoseCLRO / S&P -68.32% / 5.25% |
WinCLRO / S&P 22400.00% / 6.15% |
| 2024-Q30/3 |
LoseCLRO / S&P -4.62% / 5.89% |
LoseCLRO / S&P -45.72% / 5.89% |
LoseCLRO / S&P -455.29% / 6.11% |
| 2024-Q20/3 |
LoseCLRO / S&P -48.19% / 4.28% |
LoseCLRO / S&P -24.95% / 5.38% |
LoseCLRO / S&P -308.14% / 5.12% |
| 2024-Q11/3 |
WinCLRO / S&P 69.44% / 10.56% |
LoseCLRO / S&P -16.90% / 5.71% |
LoseCLRO / S&P -107.87% / 5.59% |
| 2023-Q41/3 |
WinCLRO / S&P 42.11% / 11.69% |
LoseCLRO / S&P -25.79% / 6.81% |
LoseCLRO / S&P -102.38% / 7.78% |
| 2023-Q30/3 |
LoseCLRO / S&P -8.43% / -3.27% |
LoseCLRO / S&P -34.58% / 7.52% |
LoseCLRO / S&P -440.00% / -5.03% |
| 2023-Q20/3 |
LoseCLRO / S&P -2.09% / 8.74% |
LoseCLRO / S&P -31.49% / 9.50% |
LoseCLRO / S&P -377.42% / -8.57% |
| 2023-Q10/3 |
LoseCLRO / S&P -0.66% / 7.50% |
LoseCLRO / S&P -25.91% / 10.77% |
LoseCLRO / S&P -334.21% / -15.69% |
| 2022-Q41/3 |
WinCLRO / S&P 181.48% / 7.56% |
LoseCLRO / S&P -12.99% / 11.88% |
LoseCLRO / S&P -315.38% / -17.99% |
| 2022-Q31/3 |
WinCLRO / S&P 0.00% / -4.88% |
LoseCLRO / S&P -6.41% / 13.47% |
LoseCLRO / S&P -600.00% / -1.41% |
| 2022-Q20/3 |
LoseCLRO / S&P -40.66% / -16.10% |
LoseCLRO / S&P -8.31% / 13.71% |
LoseCLRO / S&P -444.44% / 11.04% |
| 2022-Q10/3 |
LoseCLRO / S&P -29.46% / -4.60% |
LoseCLRO / S&P -2.96% / 15.97% |
LoseCLRO / S&P -860.00% / 42.23% |
| 2021-Q40/3 |
LoseCLRO / S&P -45.11% / 11.03% |
LoseCLRO / S&P -0.35% / 15.00% |
LoseCLRO / S&P -1400.00% / 96.40% |
| 2021-Q31/3 |
LoseCLRO / S&P -14.23% / 0.58% |
WinCLRO / S&P 13.06% / 10.77% |
LoseCLRO / S&P -111.90% / 69.42% |
| 2021-Q21/3 |
LoseCLRO / S&P -23.89% / 8.55% |
WinCLRO / S&P 30.08% / 6.58% |
LoseCLRO / S&P -119.15% / 51.81% |
| 2021-Q12/3 |
WinCLRO / S&P 58.59% / 6.17% |
WinCLRO / S&P 24.12% / -1.06% |
LoseCLRO / S&P -110.42% / 7.39% |
| 2020-Q41/3 |
LoseCLRO / S&P -0.87% / 12.15% |
WinCLRO / S&P 16.08% / -3.72% |
LoseCLRO / S&P -105.88% / -33.42% |
| 2020-Q33/3 |
WinCLRO / S&P 14.50% / 8.93% |
WinCLRO / S&P 3.46% / -2.04% |
WinCLRO / S&P -25.00% / -27.10% |
| 2020-Q20/3 |
LoseCLRO / S&P 19.05% / 20.54% |
LoseCLRO / S&P -8.31% / -0.46% |
LoseCLRO / S&P -71.69% / -27.11% |
| 2020-Q11/3 |
WinCLRO / S&P 1.20% / -19.60% |
LoseCLRO / S&P -9.94% / 3.47% |
LoseCLRO / S&P -73.18% / -14.75% |
| 2019-Q40/3 |
LoseCLRO / S&P -8.29% / 9.07% |
LoseCLRO / S&P -11.06% / 5.36% |
LoseCLRO / S&P -72.73% / 2.99% |
| 2019-Q30/3 |
LoseCLRO / S&P -18.83% / 1.70% |
LoseCLRO / S&P -14.13% / 5.02% |
LoseCLRO / S&P -73.71% / 0.21% |
| 2019-Q21/3 |
WinCLRO / S&P 10.40% / 4.30% |
LoseCLRO / S&P -21.88% / 6.64% |
LoseCLRO / S&P -17.00% / 8.65% |
| 2019-Q11/3 |
WinCLRO / S&P 61.60% / 13.65% |
LoseCLRO / S&P -27.38% / 8.12% |
LoseCLRO / S&P -2.19% / 14.29% |
| 2018-Q40/3 |
LoseCLRO / S&P -43.18% / -13.52% |
LoseCLRO / S&P -32.65% / 9.05% |
LoseCLRO / S&P 12.65% / 18.23% |
| 2018-Q31/3 |
LoseCLRO / S&P -42.86% / 7.71% |
LoseCLRO / S&P -30.22% / 10.21% |
WinCLRO / S&P 58.96% / 19.06% |
| 2018-Q21/3 |
LoseCLRO / S&P -51.57% / 3.43% |
LoseCLRO / S&P -25.32% / 9.03% |
WinCLRO / S&P 1566.67% / 14.46% |
| 2018-Q10/3 |
LoseCLRO / S&P -10.38% / -0.76% |
LoseCLRO / S&P -20.87% / 7.68% |
LoseCLRO / S&P -2714.29% / 12.46% |
| 2017-Q41/3 |
WinCLRO / S&P 21.33% / 6.64% |
LoseCLRO / S&P -14.05% / 7.03% |
LoseCLRO / S&P -738.46% / 13.82% |
| 2017-Q30/3 |
LoseCLRO / S&P -20.27% / 4.48% |
LoseCLRO / S&P -17.07% / 5.68% |
LoseCLRO / S&P -348.15% / 17.57% |
| 2017-Q20/3 |
LoseCLRO / S&P -4.56% / 3.09% |
LoseCLRO / S&P -17.33% / 4.83% |
LoseCLRO / S&P -118.18% / 17.74% |
| 2017-Q10/3 |
LoseCLRO / S&P -12.33% / 6.07% |
LoseCLRO / S&P -17.40% / 3.67% |
LoseCLRO / S&P -90.28% / 13.32% |
| 2016-Q40/3 |
LoseCLRO / S&P 1.98% / 3.82% |
LoseCLRO / S&P -15.85% / 2.09% |
LoseCLRO / S&P -63.38% / 7.05% |
| 2016-Q30/3 |
LoseCLRO / S&P 0.72% / 3.85% |
LoseCLRO / S&P -11.34% / 0.20% |
LoseCLRO / S&P -33.33% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | CLRO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 48.14% | 20.78% |
| Annualized return | 48.14% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | CLRO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -59.76% | 83.14% |
| Annualized return | -16.65% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | CLRO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -89.98% | 319.30% |
| Annualized return | -20.56% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DNA X, Inc. (SONM) | United States | $0.006B | -0.90 |
| FRANKLIN WIRELESS CORP (FKWL) | United States | $0.028B | -61.80 |
| FiEE, Inc. (FIEE) | Japan | $0.033B | 8.06 |
| Clearfield, Inc. (CLFD) | United States | $0.415B | -74.88 |
| ADTRAN Holdings, Inc. (ADTN) | United States | $0.565B | -43.25 |
| Fabrinet (FN) | $14.287B | 39.79 | |
| CIENA CORP (CIEN) | United States | $50.874B | 81.72 |